MorphoSys Gains Third Japanese Partner Through Astellas Deal

Astellas has licensed a monoclonal antibody library called HuCAL GOLD from MorphoSys, a Frankfurt, Germany-based mAb company, for use in its internal drug discovery programs. MorphoSys announced the deal, which could extend up to five years, March 28